# Dabur: how the business works

> For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Dabur India Limited · NSE: DABUR · BSE: 500096 · Sector: Fast Moving Consumer Goods

Updated for Q2 FY27 · checked 19 Nov 2026

This is the plain-text version of https://cityfort.in/stocks/dabur. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, Dabur: how the business works", with the page URL.

## In short

Households pay Dabur for Chyawanprash, Hajmola, hair oils, toothpaste and Real juices; about half of the money goes on materials, and ₹13.7 of every ₹100 that came in during FY26 was left as profit.

- Shoppers buy through distributors, small shops, supermarkets and online stores. Dabur supplied 1.52 million shops directly in FY26.
- Dabur says 27% of FY26 revenue came from outside India, from brands such as Hobi in Turkey and Namaste in the US.

## Key facts

**What does Dabur India do?**

Dabur India sells Ayurveda-based health products such as Dabur Chyawanprash and Hajmola, hair oils, toothpaste, Real juices, Badshah spices and home care products. Its FY26 consolidated revenue was ₹13,193 crore. [S1]

**How does Dabur India make money?**

Dabur India earns most of its profit from its consumer care business (health, hair, oral, skin and home care), which gave ₹2,476 crore, or 90.6%, of its ₹2,731 crore FY26 segment result. [S1]

**Who are Dabur India's customers?**

Dabur India sells to households through distributors, shops, supermarkets and online stores. No single customer gave 10% or more of its FY26 revenue, and it supplied 1.52 million shops directly that year. [S1]

**How big is Dabur India?**

Dabur India's FY26 consolidated revenue was ₹13,193 crore and its net profit ₹1,895 crore. It had 7,745 employees worldwide, 4,768 of them in India. [S1]

**Who owns Dabur India?**

Dabur India's promoter group held 66.25% of the shares on 30 Sep 2026, with none pledged. Domestic institutions held 18.35% and foreign investors 9.61%. [S41]

**How much of Dabur India's revenue comes from outside India?**

Dabur India says its international business was 27% of FY26 consolidated revenue. It sells in more than 120 countries and has 8 manufacturing locations outside India. [S1]

**How much dividend did Dabur India pay for FY26?**

Dabur India's dividend for FY26 was ₹8.25 per share: ₹2.75 interim plus a ₹5.50 final dividend recommended by the board. It paid ₹1,419 crore of dividends in cash during FY26. [S1, S16]

**Does Dabur India have much debt?**

On 31 Mar 2026 Dabur India had ₹1,063 crore of borrowings and ₹9,489 crore of cash and investments, so its cash and investments exceeded its borrowings by ₹8,426 crore. [S1]

## What does Dabur sell?

Dabur makes everyday products based on Ayurveda, India's traditional system of herbal medicine. Most are low-priced items bought again and again: a jar of Chyawanprash, a bottle of hair oil, a tube of toothpaste. Shares below are of FY26 India FMCG sales, as the annual report gives them.

- **Hair care (20% of India FMCG sales):** Dabur Amla and Vatika hair oils and shampoos. [S1]
- **Oral care (19%):** Dabur Red toothpaste, Meswak and Lal Dant Manjan tooth powder. [S1, S35]
- **Health supplements (14%):** Dabur Chyawanprash, a herbal jam eaten for immunity, and Dabur Honey. [S1]
- **Digestives and medicines (6% and 8%):** Hajmola and Pudin Hara for digestion, Sat Isabgol, and Honitus cough remedies sold over the counter. [S1, S35]
- **Juices, foods and spices (15% and 6%):** Real fruit juices, Hommade cooking pastes and Badshah spice blends. [S1]
- **Home and skin care (8% and 4%):** Odonil air fresheners, Sanifresh toilet cleaner, Gulabari rose water and OxyLife skin care. [S1, S19, S14]

## Who pays Dabur?

- **Households in India (73.0% of revenue):** They buy through distributors, small shops, supermarkets and online stores; Dabur supplied 1.52 million shops directly and reached 8.5 million in all in FY26. Their 73% share is 100% minus the international share (Cityfort calculation). [S1]
- **Households abroad (27.0% of revenue):** Middle East 27% of the international business, Africa 23%, Asia 19%, Europe 16% and the Americas 15%, the company says. [S1]
- **Customer concentration:** Dabur does not disclose revenue by customer; its FY26 accounts say no single customer gave 10% or more of revenue. [S1]

## Where the money went (FY26)

1. In FY26 Dabur's products brought in ₹13,193 crore of revenue, plus ₹600 crore of other income.
2. Herbs, oils, packaging and goods bought for resale took ₹6,824 crore. Employees took ₹1,376 crore.
3. Advertising took ₹888 crore, and other running costs such as freight and selling took ₹1,653 crore.
4. Depreciation (₹469 crore) and interest (₹145 crore) took ₹614 crore. Income tax took ₹552 crore.
5. ₹1,895 crore was left as net profit for Dabur's shareholders.

Sources: S1.

## Key numbers by year (₹ crore)

Financials: consolidated, ₹ crore. Financial year runs April to March (March year end). — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (₹ per share) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY22 | 10,889 | 2,167 | 19.9% | 1,739 | 16.0% | 9.84 | 1,802 | 374 | 1,428 | S41, S5 |
| FY23 | 11,530 | 2,162 | 18.8% | 1,707 | 14.8% | 9.64 | 1,488 | 509 | 979 | S41, S4 |
| FY24 | 12,404 | 2,400 | 19.3% | 1,843 | 14.9% | 10.4 | 2,013 | 564 | 1,450 | S41, S3 |
| FY25 | 12,563 | 2,317 | 18.4% | 1,768 | 14.1% | 9.97 | 1,987 | 570 | 1,417 | S41, S2 |
| FY26 | 13,193 | 2,435 | 18.5% | 1,895 | 14.4% | 10.69 | 2,579 | 420 | 2,158 | S41, S1 |

- EBITDA = profit before interest, tax and wear-and-tear of assets.
- Net profit is the share belonging to the company's owners.

## Balance sheet (as of 31 Mar 2026, ₹ crore)

On 31 Mar 2026 Dabur's cash and investments were ₹8,426 crore more than its borrowings; FY26 operating cash flow was ₹2,579 crore. [S1, S5, S3, S7]

| Item | Value |
| --- | --- |
| Total debt | 1,063 |
| Cash and investments | 9,489 |
| Net debt (debt minus cash) | −8,426 |
| Net worth (shareholders' money) | 11,803 |
| Debt to equity (times) | 0.09 |
| Interest cover (times) | 21 |
| Contingent liabilities | 820 |

- Borrowings were ₹868 crore on 31 Mar 2022, ₹1,158 crore on 31 Mar 2024, ₹730 crore on 31 Mar 2025 and ₹1,063 crore on 31 Mar 2026. On 30 Sep 2026 they were ₹1,242 crore.
- Cash and investments include long-term investments of ₹4,331 crore; the company counts them in its own figure of ₹9,489 crore.
- Lease liabilities (₹225 crore on 31 Mar 2026) are not counted as borrowings here.
- Contingent liabilities (claims not provided for) were ₹820 crore on 31 Mar 2026, up from ₹659 crore; sales tax claims rose to ₹684 crore from ₹62 crore.
- Debt to equity = borrowings ÷ total equity of ₹11,803 crore (Cityfort calculation from the FY26 annual report). The annual report's own ratio table gives 0.14 for FY26 (0.09 for FY25), on the company's own basis. Interest cover of 21.0 times is the company's figure.

## Who owns Dabur? (shareholding, Q2 FY27)

| Holder | % of shares |
| --- | --- |
| Promoters | 66.25% |
| Promoter shares pledged (% of promoter shares) | 0.0% |
| Foreign institutions (FII) | 9.61% |
| Indian institutions (DII) | 18.35% |
| Public | 5.79% |

Sources: S41.

## What could go wrong

### Rising material costs

Materials took ₹49.5 of every ₹100 that came in during FY26. In May 2026 Malhotra put input inflation at about 10%, and the EBITDA margin fell to 17.7% in Q2 FY27 from 18.4% a year earlier. [S1, S17, S41]

What to watch: The EBITDA margin each quarter and price increases the company announces.

### Middle East and currency swings abroad

The international business was 27% of FY26 revenue, and the Middle East was its largest region at 27%. The company described "severe headwinds in the Middle East" in Q2 FY27. [S1, S26]

What to watch: International growth in rupees and in constant currency each quarter.

### Regulators in India and the US

In 2026 the US FDA put drugs from the Silvassa plant on an import alert. India's food regulator FSSAI barred "100%" claims on some food products (stayed by the Delhi High Court), and SEBI sent a warning letter alleging a late disclosure. [S36, S32, S30, S25]

What to watch: The Delhi High Court hearing on 16 Dec 2026 and any US FDA update on Silvassa.

### New leadership and strategy

The Global CEO resigned with effect from 13 Nov 2026, and the company said there will be no new global CEO. Bhalla said a full strategy review will come back "in the next 6 to 8 months". [S24, S10]

What to watch: The revised strategy and whether FY27 revenue growth stays in double digits.

### Food business margins

Food earned ₹11.9 per ₹100 of revenue in FY26, down from ₹12.7 in FY25, and its revenue fell 4.0% in FY26 (Cityfort calculation). [S1]

What to watch: Food segment revenue and result in the quarterly filings.

### Tax claims

Claims not provided for in the accounts were ₹820 crore on 31 Mar 2026, including ₹684 crore of sales tax claims, up from ₹62 crore a year earlier. [S1]

What to watch: Contingent liabilities in the FY27 annual report.

## What to watch

Next: Q3 FY27 results (date not announced; Q3 FY26 results came on 29 Jan 2026), Date not announced yet.

- **FY27 revenue guidance:** Bhalla repeated the double-digit revenue growth guidance for FY27 on 5 Nov 2026. H1 FY27 revenue was up 11.1%.
- **Delhi High Court, 16 Dec 2026:** The court's stay on FSSAI's order about "100%" claims on some food products continues until the next hearing on 16 Dec 2026.
- **The new strategy:** Bhalla said on 5 Nov 2026 the company will return with a revised strategy "in the next 6 to 8 months", and plans 150–200 basis points (1.5–2 percentage points) more advertising spend.

## Sources

- S1: Integrated Annual Report FY26 (2025-26). Dabur India Ltd. https://www.dabur.com/digital-annual-report-2025-26/reports/dabur-annual-report-2025-26.pdf (published 6 Jul 2026)
- S2: Integrated Annual Report FY25 (2024-25). Dabur India Ltd. https://www.dabur.com/digital-annual-reports/reports/dabur-india-annual-report-2024-25.pdf (published 9 Jul 2025)
- S3: Integrated Annual Report FY24 (2023-24). Dabur India Ltd. https://www.dabur.com/digital-annual-report/dabur-report-complete.pdf (published 10 Jul 2024)
- S4: Integrated Annual Report FY23 (2022-23). Dabur India Ltd. https://www.dabur.com/digital-annual-report-2022-23/dabur-report-complete.pdf (accessed 19 Nov 2026)
- S5: Annual Report FY22 (2021-22). Dabur India Ltd. https://www.dabur.com/digital-annual-report-2021-22/Dabur-AR-2021-22.pdf (accessed 19 Nov 2026)
- S6: BRSR FY26. Dabur India Ltd. https://www.dabur.com/digital-annual-report-2025-26/reports/dabur-brsr.pdf (published 2 Jun 2026)
- S7: Q2 FY27 financial results. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q2/DIL-Financial%20Results-04.11.26.pdf (published 4 Nov 2026)
- S8: Q2 FY27 investor communication. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q2/DIL-Inv.%20Comm.-04.11.26.pdf (published 4 Nov 2026)
- S9: Q2 FY27 press release. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q2/DIL-Press%20Release-04.11.26.pdf (published 4 Nov 2026)
- S10: Q2 FY27 analyst/investor meet transcript (5 Nov 2026). Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q2/Transcript%20of%20Analyst%20Institutional%20Investor%20Meet%20held%20on%2005.11.2026.pdf (published 5 Nov 2026)
- S11: Q1 FY27 financial results. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q1/Financial%20Results.pdf (published 29 Jul 2026)
- S12: Q1 FY27 investor communication. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q1/Investor%20Comm%20Presentation.pdf (published 29 Jul 2026)
- S13: Q1 FY27 press release. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q1/Press%20Release.pdf (published 29 Jul 2026)
- S14: Q1 FY27 earnings call transcript. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2026-27/Q1/Conference%20Call%20Transcript.pdf (published 3 Aug 2026)
- S15: Q4 FY26 financial results. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q4/Results.pdf (published 7 May 2026)
- S16: Q4 FY26 investor communication. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q4/Investor%20Communication.pdf (published 7 May 2026)
- S17: Q4 FY26 earnings call transcript. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q4/Conference%20Call%20Transcript.pdf (published 12 May 2026)
- S18: Q3 FY26 investor communication. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q3/Investor%20Communication.pdf (published 29 Jan 2026)
- S19: Q3 FY26 earnings call transcript. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q3/Conference%20Call%20Transcript.pdf (published 3 Feb 2026)
- S20: Q2 FY26 earnings call transcript. Dabur India Ltd. https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q2/Conference%20Call%20Transcript.pdf (published 6 Nov 2025)
- S21: CRISIL rating reaffirmation filing (NCD, CP, bank loans). Dabur India Ltd (NSE filing of agency rating). https://nsearchives.nseindia.com/corporate/DABURIN_20112025175706_Creditrating.pdf (published 20 Nov 2025)
- S22: ICRA rating reaffirmation filing. Dabur India Ltd (NSE filing of agency rating). https://nsearchives.nseindia.com/corporate/DABURU_11032026181238_RatingEquity.pdf (published 11 Mar 2026)
- S23: Credit rating filing (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_17112026173458_CREDIT_RATING_Reg30.pdf (published 17 Nov 2026)
- S24: Resignation of Global CEO, board and KMP changes. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_04112026172329_ChangeinManagement.pdf (published 4 Nov 2026)
- S25: SEBI administrative warning letter (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_06112026162506_Letter.pdf (published 6 Nov 2026)
- S26: Update on performance and demand trends. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_06102026125213_Update.pdf (published 6 Oct 2026)
- S27: NCLT order, Sesa Care amalgamation (upload). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_26092026133123_Dabur_STXIntimation_Pronouncement_Order.pdf (published 26 Sep 2026)
- S28: NCLT order pronouncement, scheme of arrangement. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURA_25092026113223_Letter.pdf (published 25 Sep 2026)
- S29: Statement on floods impact. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABUR_27082026150417_Flood_impact.pdf (published 27 Aug 2026)
- S30: Update on letters dated 4 and 7 Aug 2026 (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABUR_25082026161904_Letterhead.pdf (published 25 Aug 2026)
- S31: NCLT order, Scheme of Amalgamation (Sesa Care). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABUR_24082026163614_NCLT_order.pdf (published 24 Aug 2026)
- S32: Delhi High Court stay order. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABUR_07082026151330_High_Court_order.pdf (published 7 Aug 2026)
- S33: GST audit observations (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABUR_04082026171531_GST.pdf (published 4 Aug 2026)
- S34: ESG rating disclosure (filed under Credit Rating head). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_30072026125859_Rating.pdf (published 30 Jul 2026)
- S35: Quarterly update Q1 FY27. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_03072026172934_Final.pdf (published 3 Jul 2026)
- S36: US FDA import alert (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_11062026201950_Importalert.pdf (published 11 Jun 2026)
- S37: Rumour verification: US drug regulator news item. Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_01062026143126_finalletter.pdf (published 1 Jun 2026)
- S38: Promoter disclosure Reg 31(4) (A C Burman). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/team_bbodade_19052026183811_DABUR.pdf (published 3 Jun 2026)
- S39: Penalty imposed (Reg 30). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_10042026222907_Penaltyletterhead.pdf (published 10 Apr 2026)
- S40: NCLT order dated 12 Mar 2026 (scheme). Dabur India Ltd (NSE/BSE filing). https://nsearchives.nseindia.in/corporate/DABURU_13032026173736_Letter.pdf (published 13 Mar 2026)
- S41: NSE results and shareholding XBRL facts (12 quarters, 5 years). NSE / Dabur India Ltd. https://www.nseindia.in/api/corporates-financial-results?index=equities&symbol=DABUR&period=Quarterly (published 19 Nov 2026)
